About
Contact & Profiles
A5113225182
Research Areas
- Cancer Immunotherapy and Biomarkers
- Bladder and Urothelial Cancer Treatments
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Ovarian cancer diagnosis and treatment
- Urinary and Genital Oncology Studies
- BRCA gene mutations in cancer
- Ethics in Clinical Research
The University of Texas MD Anderson Cancer Center
2025
University of California, Los Angeles
2022
Objectives: Immune-mediated colitis (IMC) is a common immune-related adverse event during immune checkpoint inhibitor (ICI) therapy. This case series and review aimed to highlight atypical cases of IMC explore the potential PET/CT predict imminent ICI colitis. Methods: Through descriptive, retrospective study at tertiary cancer center, we identified adult patients receiving ICIs for any between 2010 2022 who also underwent routine surveillance this time. We included had signs symptoms...
10.3390/jcm14010256
article
EN
Journal of Clinical Medicine
2025-01-04
10.1016/j.clgc.2022.08.006
article
EN
Clinical Genitourinary Cancer
2022-08-19
10.1016/j.urology.2024.05.011
article
EN
Urology
2024-05-23
Coming Soon ...